HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

Gastric bypass proven to be most effective for severely obese patients

A new NIHR-supported study has found that gastric bypass surgery is the most effective and cost-efficient option for treating severe obesity.

The cost of ignoring lung health research needs

Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.

A one-two punch against knee osteoarthritis

A minimally invasive surgery combined with an autologous adipose stem cell transplant achieves a remarkable 88% cartilage regeneration rate.

Understanding the myeloid cellular landscape in rheumatoid arthritis

Examining the macrophage populations in the synovium of patients with Rheumatoid Arthritis (RA) hopes to help uncover their role in RA pathogenesis better 

Using benzamil to treat inflammatory skin diseases

Inflammatory skin diseases like psoriasis involve interactions between skin cells (keratinocytes) and immune cells, which leads to chronic inflammation, disfiguring skin lesions, and systemic effects.

Imaging technologies for retinal biomarkers in Alzheimer’s disease

Andrew Kadis from Cambridge Vision Technology guides us through imaging technologies for retinal biomarkers in Alzheimer’s disease.

UK government strengthen their pandemic preparedness with H5 influenza vaccine

In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.

The EU’s next steps for an action plan on rare diseases

The European Economic and Social Committee (EESC) urges the EU to adopt a new approach to tackling rare diseases.

Epigenetic map creates new insights into the cause of cancer and dementia

A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.

Burosumab: The NHS has revealed a new therapy for people with rare bone disease

The NHS in England has introduced a new therapy that hopes to transform the lives of hundreds of adults living with X-linked Hypophosphatemia (XLH), this rare genetic disorder causes severe bone, dental, and skeletal issues.

Global measles cases surge in 2023: What does the future hold?

In 2023, the world saw an increase in measles cases, with an estimated 10.3 million people infected, showing a 20% rise from the previous year.

Now is the time to transform dementia care

Dementia is the leading cause of death in the UK, having a huge impact on people living with the condition, their families and the health systems supporting them. We hear from Dementia UK’s Andrew Pike, Head of Policy, Campaigns and Public Affairs, about how the UK Government can help to alleviate these pressures, most notably through aiding specialist nursing support.

Avoiding sepsis: How to protect yourself

Sepsis causes 350,000 adult deaths annually in the US alone. Sepsis Alliance focuses on raising awareness, improving education, and advocating for life-saving policies. Senior Clinical Content Advisor Marijke Vroomen Durning discusses the risk factors and best prevention methods to help in avoiding sepsis.

UK reports first case of new mpox strain

The UK Health Security Agency (UKHSA) has confirmed the first case of a new strain of mpox, known as clade 1b.

Creating a research home for ME/CFS, Long Covid, and others

Despite the significant disease burden, Myalgic encephalomyelitis (ME), previously known as chronic fatigue syndrome (CFS), lacks effective diagnostics and therapeutics. Emily Taylor, President and CEO of Solve M.E., explains why dedicated research for Infection-Associated Chronic Conditions and Illnesses (IACCIs) such as ME/CFS is vitally needed.

The growing global challenges of neurological conditions

A study that was reported on in the Lancet Neurology showed that over 3 billion people worldwide are living with neurological conditions, making these disorders the leading cause of illness and disability globally.

Understanding young onset dementia

Jules Knight, Consultant Admiral Nurse for Young Onset Dementia at Dementia UK, tells us about the prevalence of young onset dementia and some of the challenges that people living with dementia can face.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders